Krankheitskostenstudien bei Diabetes mellitus von Huppertz, E

Volltext

DB2 COMPARING BRITISH AND GERMAN DIABETES GUIDANCE WITH RESPECT TO LONGTERM OUTCOMES AND ASSOCIATED COSTS: RESULTS FROMTHE EAGLE DIABETES SIMULATION MODEL von Mueller, E, Huppertz, E, Stridde, E

Volltext

Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany von Schädlich, P K, Zeidler, H, Zink, A, Gromnica-Ihle, E, Schneider, M, Straub, C, Brecht, J G, Huppertz, E

Volltext

PDB1 BETTER HBA1C CONTROL WITH BOT VERSUS CT AVOIDS LONG-TERM MICRO-VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE-2-DIABETES: MODEL SIMULATIONS WITH THE DMM von Walzer, S, Huppertz, E, Mueller, E, Janka, HU

Volltext

PCN59 ECONOMIC BURDEN OF TREATING VIN AND VAIN 2/3 IN GERMANY von Schulz-Holstege, O, Hampl, M, Huppertz, E, Schmitter, S, Bönte, M, Kok, P

Volltext

PDB48 KNOWLEDGE ABOUT INSULIN AND WILLINGNESS TO USE IT INFLUENCE GLYCEMIC CONTROL IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ONLY TREATED WITH ORAL ANTIDIABETIC DRUGS—A GERMAN SURV... von Stridde, E, Göke, B, Huppertz, E, Weitkunat, R, Crispin, A

Volltext

PDB32 ECONOMIC EVALUATION OF THE LAPTOP-STUDY RESULTS von Högy, B, Janka, HU, Huppertz, E

Volltext

PDB32 LONG-TERM DIABETES COMPLICATIONS: INFLUENCE OF DELAY IN STARTING INTENSIFIED THERAPY AND OF PATIENT RATES TREATED TO TARGET A1C.ANALYSES WITH THE DIABETES MELLITUS MODEL (DMM... von Bergemann, R, Huppertz, E, Mueller, E, Maxion-Bergemann, S

Volltext

Cost effectiveness of ramipril in patients at high risk for cardiovascular events: Economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for germany from the... von SCHÄDLICH, Peter K, BRECHT, Josef Georg, RANGOONWALA, Badrudin, HUPPERTZ, Eduard

Volltext

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany. I. Selected DMARDs and patient-related costs von SCHÄDLICH, Peter K, ZEIDLER, Henning, ZINK, Angela, GROMNICA-IHLE, Erika, SCHNEIDER, Matthias, STRAUB, Christoph, BRECHT, Josef G, HUPPERTZ, Eduard

Volltext

PCV37 ECONOMIC EVALUATION OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) GUIDED CARDIOVERSION IN THE ANTICOAGULATION IN CARDIOVERSION USING ENOXAPARIN (ACE) TRIAL FROM THE PERSPECTIVE O... von Schadlich, PK, Lehmacher, W, Huppertz, E, Grewe, R, Brecht, JG

Volltext

PDB1 IMPROVED GLYCAEMIC CONTROL AND LESS HYPOGLYCAEMIA WITH INSULIN GLARGINE COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES LEADS TO FEWER LONG-TERM COMPLICATIONS—RESUL... von Maxion-Bergemann, S, Müller, E, Bergemann, R, Walleser, S, Huppertz, E

Volltext

PIN16 ECONOMIC BURDEN AND FACTORS INFLUENCING COSTS IN GERMAN PATIENTS HOSPITALISED FOR COMMUNITYACQUIRED PNEUMONIA (CAP) von Decker-Burgard, S, Ehrnsperger, M, Eichmann, FRW, Huppertz, E, Kreyenberg, K, Reitberger, U, Roscher, K, Spannheimer, A

Volltext

Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the... von Schädlich, P K, Brecht, J G, Brunetti, M, Pagano, E, Rangoonwala, B, Huppertz, E

Volltext

PIN2: TELITHROMYCIN (TEL) RESULTS IN FEWER HOSPITALIZATIONS THAN AMOXICILLINCLAVULANATE (AMC) IN THE OUTPATIENT TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS (AECB) von Chang, JR, Stewart, J, Cadilhac, M, Huppertz, E, Nieman, RB

Volltext

Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from th... von Schädlich, P K, Huppertz, E, Brecht, J G

Volltext

PCV39 ECONOMIC EVALUATION OF THE MEDENOX (PROPHYLAXIS IN MEDICAL PATIENTS WITH ENOXAPARIN) TRIAL FROM THE PERSPECTIVE OF HOSPITALS IN GERMANY: RESULTS OF A SUBGROUP ANALYSIS von Schädlich, PK, Kentsch, M, Weber, M, Kämmerer, W, Nadipelli, V, Huppertz, E, Brecht, JG

Volltext

PCD9: COST-EFFECTIVENESS OF RAMIPRIL IN HYPERTENSIVE PATIENTS WITH NEPHROPATHY IN GERMANY von Schadlich, PK, Brecht, JG, Huppertz, E

Volltext

Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM) von Hauner, H, Maxion-Bergemann, S, Müller, E, Schulz, M, Huppertz, E, Bergemann, R

Volltext

PIN22: TELITHROMYCIN (TEL) IS AN EFFECTIVE THERAPY FOR ADULT OUTPATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AND IS ASSOCIATED WITH LOWER OVERALL HEALTHCARE COSTS THAN CLARITHR... von Davey, PG, Chang, JR, Stewart, J, Asche, CV, Huppertz, E, Cadilhac, M, Nieman, RB

Volltext